TREACE MEDICAL CONCEPTS INC (TMCI) Fundamental Analysis & Valuation

NASDAQ:TMCI • US89455T1097

Current stock price

1.22 USD
0 (0%)
Last:

This TMCI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. TMCI Profitability Analysis

1.1 Basic Checks

  • In the past year TMCI has reported negative net income.
  • TMCI had a negative operating cash flow in the past year.
  • In the past 5 years TMCI always reported negative net income.
  • In the past 5 years TMCI always reported negative operating cash flow.
TMCI Yearly Net Income VS EBIT VS OCF VS FCFTMCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -10M -20M -30M -40M -50M

1.2 Ratios

  • TMCI has a Return On Assets (-30.96%) which is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of -67.56%, TMCI is in line with its industry, outperforming 44.15% of the companies in the same industry.
Industry RankSector Rank
ROA -30.96%
ROE -67.56%
ROIC N/A
ROA(3y)-25.43%
ROA(5y)-23.58%
ROE(3y)-50.95%
ROE(5y)-49.16%
ROIC(3y)N/A
ROIC(5y)N/A
TMCI Yearly ROA, ROE, ROICTMCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400 -500

1.3 Margins

  • TMCI has a better Gross Margin (79.81%) than 93.09% of its industry peers.
  • In the last couple of years the Gross Margin of TMCI has remained more or less at the same level.
  • TMCI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 79.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.33%
GM growth 5Y0.4%
TMCI Yearly Profit, Operating, Gross MarginsTMCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. TMCI Health Analysis

2.1 Basic Checks

  • TMCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for TMCI has been increased compared to 1 year ago.
  • TMCI has more shares outstanding than it did 5 years ago.
  • TMCI has a worse debt/assets ratio than last year.
TMCI Yearly Shares OutstandingTMCI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
TMCI Yearly Total Debt VS Total AssetsTMCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • TMCI has an Altman-Z score of -0.55. This is a bad value and indicates that TMCI is not financially healthy and even has some risk of bankruptcy.
  • TMCI has a Altman-Z score (-0.55) which is in line with its industry peers.
  • TMCI has a Debt/Equity ratio of 0.64. This is a neutral value indicating TMCI is somewhat dependend on debt financing.
  • The Debt to Equity ratio of TMCI (0.64) is worse than 64.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Altman-Z -0.55
ROIC/WACCN/A
WACC11.25%
TMCI Yearly LT Debt VS Equity VS FCFTMCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 4.31 indicates that TMCI has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 4.31, TMCI is doing good in the industry, outperforming 69.68% of the companies in the same industry.
  • TMCI has a Quick Ratio of 3.13. This indicates that TMCI is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of TMCI (3.13) is better than 65.96% of its industry peers.
Industry RankSector Rank
Current Ratio 4.31
Quick Ratio 3.13
TMCI Yearly Current Assets VS Current LiabilitesTMCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. TMCI Growth Analysis

3.1 Past

  • TMCI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.59%.
  • The Revenue has been growing slightly by 1.59% in the past year.
  • The Revenue has been growing by 29.95% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-10.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1400%
Revenue 1Y (TTM)1.59%
Revenue growth 3Y14.47%
Revenue growth 5Y29.95%
Sales Q2Q%-9.01%

3.2 Future

  • The Earnings Per Share is expected to grow by 4.22% on average over the next years.
  • The Revenue is expected to grow by 2.59% on average over the next years.
EPS Next Y7.4%
EPS Next 2Y7.07%
EPS Next 3Y4.22%
EPS Next 5YN/A
Revenue Next Year-3.13%
Revenue Next 2Y2.12%
Revenue Next 3Y2.59%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TMCI Yearly Revenue VS EstimatesTMCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
TMCI Yearly EPS VS EstimatesTMCI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6 -0.8

More info and screens

Find the best growth stocksShow best growing peers

0

4. TMCI Valuation Analysis

4.1 Price/Earnings Ratio

  • TMCI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TMCI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TMCI Price Earnings VS Forward Price EarningsTMCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TMCI Per share dataTMCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.07%
EPS Next 3Y4.22%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TMCI Dividend Analysis

5.1 Amount

  • TMCI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TMCI Fundamentals: All Metrics, Ratios and Statistics

TREACE MEDICAL CONCEPTS INC

NASDAQ:TMCI (3/30/2026, 9:54:03 AM)

1.22

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-27
Earnings (Next)05-06
Inst Owners56.35%
Inst Owner Change-9.54%
Ins Owners24.03%
Ins Owner Change-0.49%
Market Cap78.80M
Revenue(TTM)212.69M
Net Income(TTM)-59.00M
Analysts50.91
Price Target3.63 (197.54%)
Short Float %7.94%
Short Ratio4.5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.46%
Min EPS beat(2)1.96%
Max EPS beat(2)8.96%
EPS beat(4)4
Avg EPS beat(4)8.6%
Min EPS beat(4)1.96%
Max EPS beat(4)18.69%
EPS beat(8)8
Avg EPS beat(8)15.45%
EPS beat(12)10
Avg EPS beat(12)10.57%
EPS beat(16)13
Avg EPS beat(16)10.63%
Revenue beat(2)0
Avg Revenue beat(2)-0.58%
Min Revenue beat(2)-1.01%
Max Revenue beat(2)-0.16%
Revenue beat(4)0
Avg Revenue beat(4)-0.86%
Min Revenue beat(4)-1.26%
Max Revenue beat(4)-0.16%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)7
Avg Revenue beat(12)0.32%
Revenue beat(16)11
Avg Revenue beat(16)2.04%
PT rev (1m)-10.94%
PT rev (3m)-33.26%
EPS NQ rev (1m)-20.98%
EPS NQ rev (3m)-19.31%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.39%
Revenue NQ rev (1m)-9.05%
Revenue NQ rev (3m)-12.11%
Revenue NY rev (1m)-2.35%
Revenue NY rev (3m)-4.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B 0.9
P/tB 1.17
EV/EBITDA N/A
EPS(TTM)-0.94
EYN/A
EPS(NY)-0.87
Fwd EYN/A
FCF(TTM)-0.46
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS3.29
BVpS1.35
TBVpS1.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -30.96%
ROE -67.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 79.81%
FCFM N/A
ROA(3y)-25.43%
ROA(5y)-23.58%
ROE(3y)-50.95%
ROE(5y)-49.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.33%
GM growth 5Y0.4%
F-Score2
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 127.24%
Cap/Sales 6.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.31
Quick Ratio 3.13
Altman-Z -0.55
F-Score2
WACC11.25%
ROIC/WACCN/A
Cap/Depr(3y)159.68%
Cap/Depr(5y)313.7%
Cap/Sales(3y)6.01%
Cap/Sales(5y)6.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1400%
EPS Next Y7.4%
EPS Next 2Y7.07%
EPS Next 3Y4.22%
EPS Next 5YN/A
Revenue 1Y (TTM)1.59%
Revenue growth 3Y14.47%
Revenue growth 5Y29.95%
Sales Q2Q%-9.01%
Revenue Next Year-3.13%
Revenue Next 2Y2.12%
Revenue Next 3Y2.59%
Revenue Next 5YN/A
EBIT growth 1Y2.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.69%
EBIT Next 3Y19.71%
EBIT Next 5YN/A
FCF growth 1Y39.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.03%
OCF growth 3YN/A
OCF growth 5YN/A

TREACE MEDICAL CONCEPTS INC / TMCI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for TREACE MEDICAL CONCEPTS INC?

ChartMill assigns a fundamental rating of 2 / 10 to TMCI.


What is the valuation status of TREACE MEDICAL CONCEPTS INC (TMCI) stock?

ChartMill assigns a valuation rating of 0 / 10 to TREACE MEDICAL CONCEPTS INC (TMCI). This can be considered as Overvalued.


Can you provide the profitability details for TREACE MEDICAL CONCEPTS INC?

TREACE MEDICAL CONCEPTS INC (TMCI) has a profitability rating of 2 / 10.


What is the earnings growth outlook for TREACE MEDICAL CONCEPTS INC?

The Earnings per Share (EPS) of TREACE MEDICAL CONCEPTS INC (TMCI) is expected to grow by 7.4% in the next year.